Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Eric Bussear

Physician Assistant Miami, FL Physician Assistant

NPI 1336160258 CMS profile 11179328

11760 Bird Rd, Suite 451, Miami, FL 33175

Open in the dashboard

General payments

$22,964

191 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Eric Bussear of Miami, FL is reported in the CMS Open Payments database as having received $22,964 across 191 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $851 41
2023 General $18 1
2022 General $10,836 72
2021 General $11,260 77

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Eric Bussear
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Eric Bussear were reported at $851. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Eric Bussear Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $11,260 $132 $37–$438 $132
2022 $10,836 $155 $48–$522 $149
2023 $18 $167 $52–$557 $160
2024 $0 $178 $55–$600 $164
2025 $851 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $15,916 58 payments
  2. Sun Pharmaceutical Industries Inc. $2,587 19 payments
  3. UCB, Inc. $2,343 23 payments
  4. Pfizer Inc. $429 20 payments
  5. Novartis Pharmaceuticals Corporation $314 12 payments
  6. Incyte Corporation $272 5 payments
  7. Janssen Biotech, Inc. $247 12 payments
  8. Lilly USA, LLC $177 9 payments
  9. Genzyme Corporation $128 6 payments
  10. Regeneron Healthcare Solutions, Inc. $78 3 payments
  11. Other $472 24 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $16,975 16 payments
  2. Food and Beverage $3,822 169 payments
  3. Consulting Fee $1,875 2 payments
  4. Education $292 4 payments
Products named General payments · program years 2021–2025
  1. SKYRIZI Immunology $10,829 26 payments
  2. ILUMYA $2,377 18 payments
  3. RINVOQ $1,421 15 payments
  4. HUMIRA $1,015 8 payments
  5. CIBINQO $251 10 payments
  6. EUCRISA $226 14 payments
  7. COSENTYX $224 8 payments
  8. TREMFYA $220 10 payments
  9. SKYRIZI Immunology $165 8 payments
  10. Bimzelx $159 10 payments
  11. Other $1,499 77 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

191 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record